by Cort Johnson | Apr 24, 2025 | Antivirals , Apheresis , Apheresis , Drugs , Homepage , Immune , Ivabradine , IVIG , Ketamine , Klimas , long COVID , ME/CFS , Metabolism , Metformin , Monoclonal antibodies , Plasmapheresis , Rapamycin , Treatment
Big pharma is largely staying clear of long COVID trials but the many small and some quite large clinical trials are underway provide hope.
by Cort Johnson | Mar 20, 2025 | Energy Production , Homepage , long COVID , Metabolism , Muscles , Purine inhibitors , Research , Suramin , Treatment
A long COVID invasive exercise metabolomic study found reduced energy production and recommended purine inhibiting drugs.
by Cort Johnson | Mar 13, 2025 | B-cells , Clotting , COVID-19 , Homepage , Immune , Inflammation , Lipids , Pathogens , Plasmapheresis , Research , Treatment
Check out how blood cleansing techniques to remove pathogenic factors in chronic fatigue syndrome (ME/CFS) and long COVID may (or may not) be helping in these diseases.
by Cort Johnson | Feb 21, 2025 | Drugs , Homepage , Low Dose Naltrexone , Nalmafine , Rapamycin , Treatment , Vagus nerve stimulation
Nalmefene may work better than low-dose naltrexone in ME/CFS, fibromyalgia, and long COVID, plus LDN and Rapamycin may help with osteoporosis.
by Cort Johnson | Feb 1, 2025 | Autophagy , Bateman , Energy Production , Homepage , Inflammation , Kaufman , Peterson , Rapamycin , Treatment
A successful rapamycin clinical trial in chronic fatigue syndrome (ME/CFS) leads to more studies and perhaps FDA approval
by Cort Johnson | Jan 15, 2025 | Autonomic Nervous System , Drugs , Epigenetics , Genetics , Homepage , Immune , Monocytes , Research , T-cells
Evidence indicating that the T-cells in ME/CFS are exhausted could lead to new treatment options.